Senators are joining calls for an investigation into whether the Obama administration enabled drug maker Mylan to bilk Medicaid.

The Senate Finance Committee wrote to the Obama administration on Tuesday to examine whether there is enough oversight of the Medicaid Drug Rebate Program, after concerns that Mylan allegedly manipulated the program to avoid having to pay a higher rebate. The senators join a House effort seeking answers on the rebate.